Betta Historical Balance Sheet

300558 Stock

49.36 3.74 7.04%

Trend analysis of Betta Pharmaceuticals Co balance sheet accounts such as Other Current Liab of 3.9 M, Total Current Liabilities of 1.9 B or Total Stockholder Equity of 5.5 B provides information on Betta Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Betta Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Betta Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Betta Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Betta Pharmaceuticals is a good buy for the upcoming year.

Betta Pharmaceuticals Inventory

343.88 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Betta Pharmaceuticals Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Betta Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Betta Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Betta Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Betta Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Betta currently owns. An asset can also be divided into two categories, current and non-current.

Betta Pharmaceuticals Balance Sheet Chart

At present, Betta Pharmaceuticals' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 1.9 B, whereas Other Current Liabilities is forecasted to decline to about 3.9 M.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity Retained Earnings Net Invested Capital

Total Assets

Total assets refers to the total amount of Betta Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Betta Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Betta Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Betta Pharmaceuticals Co are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Most accounts from Betta Pharmaceuticals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Betta Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Betta Pharmaceuticals Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	95.8M	1.6M	4.1M	3.9M
Total Assets	6.3B	7.9B	9.1B	9.6B

Other Current Liab Total Assets

Betta Pharmaceuticals balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Short Term Investments	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Retained Earnings	Net Tangible Assets	Other Stockholder Equity	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Non Current Assets Total
Total Assets		-0.26	0.94	0.98	0.94	0.93	0.71	0.91	0.91	0.89	-0.14	0.98	0.94	0.96	0.99	0.66	0.97	0.88	0.86	0.92	0.96	-0.75	0.81	0.78	0.83	0.93
Other Current Liab	-0.26		-0.46	-0.15	-0.02	-0.54	0.24	0.04	-0.29	-0.5	0.24	-0.29	-0.11	-0.4	-0.23	0.12	-0.2	0.05	-0.04	-0.21	-0.08	-0.02	0.21	-0.05	0.15	-0.24
Total Current Liabilities	0.94	-0.46		0.88	0.84	0.94	0.52	0.82	0.84	0.95	-0.27	0.95	0.85	0.97	0.93	0.53	0.91	0.76	0.73	0.84	0.87	-0.68	0.7	0.64	0.72	0.91
Total Stockholder Equity	0.98	-0.15	0.88		0.93	0.88	0.79	0.9	0.85	0.86	-0.04	0.97	0.93	0.9	0.97	0.72	0.97	0.93	0.91	0.9	0.96	-0.74	0.86	0.85	0.87	0.91
Other Liab	0.94	-0.02	0.84	0.93		0.8	0.8	0.97	0.88	0.76	-0.2	0.91	0.93	0.89	0.95	0.59	0.88	0.87	0.85	0.95	0.99	-0.86	0.84	0.78	0.84	0.89
Accounts Payable	0.93	-0.54	0.94	0.88	0.8		0.48	0.75	0.89	0.91	-0.26	0.92	0.88	0.95	0.93	0.47	0.9	0.71	0.72	0.85	0.85	-0.6	0.59	0.65	0.63	0.87
Cash	0.71	0.24	0.52	0.79	0.8	0.48		0.78	0.55	0.49	-0.04	0.71	0.67	0.55	0.72	0.64	0.65	0.85	0.88	0.72	0.81	-0.77	0.77	0.85	0.77	0.71
Other Assets	0.91	0.04	0.82	0.9	0.97	0.75	0.78		0.84	0.7	-0.18	0.89	0.91	0.87	0.92	0.63	0.88	0.87	0.8	0.87	0.97	-0.91	0.91	0.7	0.91	0.88
Long Term Debt	0.91	-0.29	0.84	0.85	0.88	0.89	0.55	0.84		0.7	-0.22	0.83	0.87	0.95	0.91	0.49	0.85	0.69	0.68	0.87	0.88	-0.69	0.62	0.59	0.67	0.82
Net Receivables	0.89	-0.5	0.95	0.86	0.76	0.91	0.49	0.7	0.7		-0.15	0.93	0.79	0.88	0.87	0.53	0.88	0.74	0.75	0.81	0.79	-0.56	0.64	0.72	0.65	0.86
Short Term Investments	-0.14	0.24	-0.27	-0.04	-0.2	-0.26	-0.04	-0.18	-0.22	-0.15		-0.16	-0.19	-0.27	-0.24	0.35	-0.07	0.04	0.05	-0.14	-0.22	0.21	0.11	0.17	0.09	-0.26
Inventory	0.98	-0.29	0.95	0.97	0.91	0.92	0.71	0.89	0.83	0.93	-0.16		0.93	0.93	0.98	0.64	0.96	0.89	0.87	0.91	0.95	-0.76	0.81	0.81	0.82	0.94
Other Current Assets	0.94	-0.11	0.85	0.93	0.93	0.88	0.67	0.91	0.87	0.79	-0.19	0.93		0.89	0.96	0.61	0.95	0.86	0.8	0.89	0.95	-0.77	0.8	0.7	0.82	0.89
Total Liab	0.96	-0.4	0.97	0.9	0.89	0.95	0.55	0.87	0.95	0.88	-0.27	0.93	0.89		0.96	0.53	0.92	0.75	0.73	0.88	0.91	-0.71	0.69	0.63	0.73	0.91
Intangible Assets	0.99	-0.23	0.93	0.97	0.95	0.93	0.72	0.92	0.91	0.87	-0.24	0.98	0.96	0.96		0.6	0.96	0.87	0.85	0.93	0.98	-0.78	0.79	0.77	0.81	0.94
Common Stock	0.66	0.12	0.53	0.72	0.59	0.47	0.64	0.63	0.49	0.53	0.35	0.64	0.61	0.53	0.6		0.72	0.79	0.66	0.49	0.61	-0.51	0.75	0.57	0.77	0.62
Property Plant Equipment	0.97	-0.2	0.91	0.97	0.88	0.9	0.65	0.88	0.85	0.88	-0.07	0.96	0.95	0.92	0.96	0.72		0.9	0.82	0.84	0.92	-0.69	0.84	0.73	0.86	0.91
Retained Earnings	0.88	0.05	0.76	0.93	0.87	0.71	0.85	0.87	0.69	0.74	0.04	0.89	0.86	0.75	0.87	0.79	0.9		0.94	0.79	0.9	-0.79	0.92	0.84	0.95	0.9
Net Tangible Assets	0.86	-0.04	0.73	0.91	0.85	0.72	0.88	0.8	0.68	0.75	0.05	0.87	0.8	0.73	0.85	0.66	0.82	0.94		0.85	0.87	-0.76	0.82	0.95	0.85	0.88
Other Stockholder Equity	0.92	-0.21	0.84	0.9	0.95	0.85	0.72	0.87	0.87	0.81	-0.14	0.91	0.89	0.88	0.93	0.49	0.84	0.79	0.85		0.93	-0.79	0.7	0.83	0.72	0.86
Deferred Long Term Liab	0.96	-0.08	0.87	0.96	0.99	0.85	0.81	0.97	0.88	0.79	-0.22	0.95	0.95	0.91	0.98	0.61	0.92	0.9	0.87	0.93		-0.85	0.85	0.8	0.86	0.92
Long Term Investments	-0.75	-0.02	-0.68	-0.74	-0.86	-0.6	-0.77	-0.91	-0.69	-0.56	0.21	-0.76	-0.77	-0.71	-0.78	-0.51	-0.69	-0.79	-0.76	-0.79	-0.85		-0.8	-0.65	-0.83	-0.81
Short Long Term Debt	0.81	0.21	0.7	0.86	0.84	0.59	0.77	0.91	0.62	0.64	0.11	0.81	0.8	0.69	0.79	0.75	0.84	0.92	0.82	0.7	0.85	-0.8		0.73	0.98	0.78
Total Current Assets	0.78	-0.05	0.64	0.85	0.78	0.65	0.85	0.7	0.59	0.72	0.17	0.81	0.7	0.63	0.77	0.57	0.73	0.84	0.95	0.83	0.8	-0.65	0.73		0.73	0.74
Short Term Debt	0.83	0.15	0.72	0.87	0.84	0.63	0.77	0.91	0.67	0.65	0.09	0.82	0.82	0.73	0.81	0.77	0.86	0.95	0.85	0.72	0.86	-0.83	0.98	0.73		0.85
Non Current Assets Total	0.93	-0.24	0.91	0.91	0.89	0.87	0.71	0.88	0.82	0.86	-0.26	0.94	0.89	0.91	0.94	0.62	0.91	0.9	0.88	0.86	0.92	-0.81	0.78	0.74	0.85

Click cells to compare fundamentals

Betta Pharmaceuticals Account Relationship Matchups

Betta Pharmaceuticals balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	4.1B	5.2B	6.3B	7.9B	9.1B	9.6B
Other Current Liab	148.2M	136.9M	95.8M	1.6M	4.1M	3.9M
Total Current Liabilities	705.2M	438.1M	888.9M	2.1B	1.8B	1.9B
Total Stockholder Equity	2.5B	4.1B	4.6B	4.8B	5.3B	5.5B
Other Liab	227.3M	678.9M	644.6M	690.4M	794.0M	833.7M
Accounts Payable	29.2M	113.6M	431.2M	591.0M	800.1M	840.1M
Cash	521.3M	1.3B	792.0M	731.3M	752.0M	466.3M
Other Assets	1.1B	1.5B	1.3B	1.3B	1.5B	1.6B
Net Receivables	57.7M	52.6M	214.1M	433.3M	286.4M	300.7M
Inventory	134.6M	188.6M	293.3M	372.2M	327.5M	343.9M
Other Current Assets	78.7M	63.9M	153.5M	93.8M	140.4M	147.4M
Total Liab	1.7B	1.1B	1.6B	3.0B	3.8B	4.0B
Intangible Assets	1.4B	1.8B	2.4B	2.7B	3.2B	3.3B
Property Plant Equipment	815.1M	789.9M	775.7M	1.3B	1.5B	1.6B
Retained Earnings	1.4B	1.9B	2.1B	2.0B	2.3B	1.2B
Net Tangible Assets	1.3B	1.5B	3.1B	3.0B	3.4B	2.0B
Other Stockholder Equity	4.3M	51.9M	52.3M	74.6M	85.8M	90.1M
Deferred Long Term Liab	565.5M	913.1M	1.2B	1.3B	1.4B	1.5B
Total Current Assets	792.2M	1.8B	1.7B	1.7B	1.5B	1.3B
Non Current Assets Total	3.3B	3.4B	4.6B	6.2B	7.6B	4.3B
Non Currrent Assets Other	1.4M	50.8M	1.1M	6.6M	16.5M	15.7M
Non Current Liabilities Total	958.9M	647.2M	696.8M	847.7M	2.0B	2.1B
Net Invested Capital	3.1B	4.1B	4.6B	5.9B	7.4B	4.8B
Net Working Capital	87.0M	1.4B	765.1M	(371.9M)	(277.3M)	(263.4M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Other Information on Investing in Betta Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Betta Historical Balance Sheet

Betta Pharmaceuticals Inventory

343.88 Million

About Betta Balance Sheet Analysis

Betta Pharmaceuticals Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Retained Earnings

Net Invested Capital

Betta Pharmaceuticals balance sheet Correlations

Betta Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Betta Pharmaceuticals balance sheet Accounts

Also Currently Popular

Other Information on Investing in Betta Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Intangible Assets	+ 0.99	Total Assets
Deferred Long Term Liab	+ 0.99	Other Liab
Total Stockholder Equity	+ 0.98	Total Assets
Inventory	+ 0.98	Total Assets
Intangible Assets	+ 0.98	Inventory
Deferred Long Term Liab	+ 0.98	Intangible Assets

Long Term Investments	- 0.91	Other Assets
Long Term Investments	- 0.86	Other Liab
Long Term Investments	- 0.85	Deferred Long Term Liab
Short Term Debt	- 0.83	Long Term Investments
Non Current Assets Total	- 0.81	Long Term Investments
Short Long Term Debt	- 0.8	Long Term Investments